The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Consolidation reduced dose whole brain radiotherapy (rdWBRT) following methotrexate, rituximab, procarbazine, vincristine, cytarabine (R-MPV-A) for newly diagnosed primary CNS lymphoma (PCNSL): Final results and long-term outcome.
Richard Charles Curry
No relevant relationships to disclose
Denise Correa
No relevant relationships to disclose
Jeffrey J. Raizer
No relevant relationships to disclose
Sean Aaron Grimm
No relevant relationships to disclose
Rose Lai
No relevant relationships to disclose
David Schiff
No relevant relationships to disclose
Barbara W. Grant
No relevant relationships to disclose
Anne S. Reiner
No relevant relationships to disclose
Katherine Panageas
No relevant relationships to disclose
Joachim Yahalom
No relevant relationships to disclose
Lisa Marie DeAngelis
No relevant relationships to disclose
Lauren E. Abrey
Employment or Leadership Position - Roche
Patrick Glyn Morris
No relevant relationships to disclose
Antonio Marcilio Padula Omuro
No relevant relationships to disclose